JP7794745B2 - 動物質を含まない食事性コラーゲン - Google Patents

動物質を含まない食事性コラーゲン

Info

Publication number
JP7794745B2
JP7794745B2 JP2022545046A JP2022545046A JP7794745B2 JP 7794745 B2 JP7794745 B2 JP 7794745B2 JP 2022545046 A JP2022545046 A JP 2022545046A JP 2022545046 A JP2022545046 A JP 2022545046A JP 7794745 B2 JP7794745 B2 JP 7794745B2
Authority
JP
Japan
Prior art keywords
polypeptide
naturally occurring
collagen
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022545046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513435A (ja
JP2023513435A5 (https=
Inventor
ニコライ ウズノフ，
ジェフリー アール． メリン，
ジュリア コー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geltor Inc
Original Assignee
Geltor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltor Inc filed Critical Geltor Inc
Publication of JP2023513435A publication Critical patent/JP2023513435A/ja
Publication of JP2023513435A5 publication Critical patent/JP2023513435A5/ja
Application granted granted Critical
Publication of JP7794745B2 publication Critical patent/JP7794745B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
JP2022545046A 2020-01-24 2021-01-22 動物質を含まない食事性コラーゲン Active JP7794745B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062965700P 2020-01-24 2020-01-24
US62/965,700 2020-01-24
US202063117243P 2020-11-23 2020-11-23
US63/117,243 2020-11-23
PCT/US2021/014714 WO2021150959A1 (en) 2020-01-24 2021-01-22 Animal-free dietary collagen

Publications (3)

Publication Number Publication Date
JP2023513435A JP2023513435A (ja) 2023-03-31
JP2023513435A5 JP2023513435A5 (https=) 2024-01-31
JP7794745B2 true JP7794745B2 (ja) 2026-01-06

Family

ID=76991717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022545046A Active JP7794745B2 (ja) 2020-01-24 2021-01-22 動物質を含まない食事性コラーゲン

Country Status (11)

Country Link
US (3) US11174300B2 (https=)
EP (1) EP4093761A4 (https=)
JP (1) JP7794745B2 (https=)
CN (1) CN115298212A (https=)
AU (1) AU2021211721A1 (https=)
BR (1) BR112022014586A2 (https=)
CA (1) CA3168802A1 (https=)
GB (1) GB2610313B (https=)
MX (1) MX2022009036A (https=)
TW (1) TW202134267A (https=)
WO (1) WO2021150959A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3953380A4 (en) 2019-04-12 2023-01-25 Geltor, Inc. RECOMBINATION ELASTIN AND ASSOCIATED PRODUCTION
GB2610313B (en) 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen
EP4376872A4 (en) * 2021-07-28 2025-10-29 Geltor Inc Pharmaceutical compositions and methods for treating connective tissue disorders with collagen polypeptides
WO2023009673A1 (en) * 2021-07-28 2023-02-02 Geltor, Inc. Animal-free cosmetic collagens
CN116218864B (zh) * 2023-04-10 2024-01-09 山东多美康生物医药有限公司 一种重组Ⅲ型人源化胶原蛋白α1及其表达载体和应用
TW202446787A (zh) * 2023-05-17 2024-12-01 美商Ｈｔｌ生物科技創新股份有限公司 膠原蛋白生產程序
CN118255873B (zh) * 2024-04-30 2024-11-22 安徽中生安兰健康产业有限公司 重组人源iii型胶原蛋白及基因、表达载体、菌和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003516730A (ja) 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2019068018A2 (en) 2017-09-28 2019-04-04 Geltor, Inc. RECOMBINANT COLLAGEN AND ELASTIN MOLECULES AND USES THEREOF

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
WO1997038710A1 (en) 1996-04-12 1997-10-23 Fibrogen, Inc. Synthesis of human procollagens and collagens in recombinant dna systems
FR2757874B1 (fr) 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
TW499433B (en) * 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
CN1500876A (zh) * 2002-11-14 2004-06-02 �й������ž�����ҽѧ��ѧԺ����ҽ 一种编码鸡ⅱ型胶原蛋白的全长多核苷酸序列及其用途
EP1584630A1 (en) 2004-04-08 2005-10-12 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for preparing a modified protein outside a host cell
DE602006015289D1 (de) 2005-02-23 2010-08-19 Fujifilm Mfg Europe Bv Nicht-glycosylierte rekombinante collagen-ähnliche polypeptide
AU2006255140A1 (en) 2005-06-03 2006-12-14 The Texas A & M University System Specific binding sites in collagen for integrins and use thereof
WO2007044945A2 (en) 2005-10-13 2007-04-19 Gu, Jennifer, L. Mineral collagen chelates and methods of making and using same
US7279329B2 (en) 2005-10-17 2007-10-09 Industrial Technology Research Institute Expression system for producing collagen
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
ATE455153T1 (de) 2006-03-13 2010-01-15 Becker & Co Naturinwerk Kollagenpulver und auf kollagen basierende thermoplastische zusammensetzung zur herstellung von formkörpern
EP2054442A2 (en) * 2006-06-14 2009-05-06 Cell-Matrix, Inc. Denatured collagen peptides and uses thereof
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
WO2009053985A1 (en) 2007-10-26 2009-04-30 Collplant Ltd. Methods of processing recombinant procollagen
US7910134B2 (en) 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8507652B2 (en) 2008-02-08 2013-08-13 Luis Eduardo da Cruz Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
GB0820784D0 (en) * 2008-11-13 2008-12-24 Nordic Bioscience As Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments
WO2010091251A2 (en) 2009-02-06 2010-08-12 The University Of Medicine And Dentistry Of New Jersey Modular triple-helical collagen-like products
EP2770327B1 (en) * 2009-03-30 2017-06-14 Nordic Bioscience A/S Fibrosis biomarker assay
EP2454367B1 (en) 2009-07-17 2013-10-16 The Texas A&M University System Designer collagens and uses thereof
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
CN103641896B (zh) * 2009-11-19 2015-08-05 浙江大学 明胶样单元的用途
EP2566516B1 (en) * 2010-05-03 2019-07-03 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
US9040484B2 (en) 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
EP2753704A4 (en) 2011-08-03 2015-07-08 Lotus Tissue Repair Inc COLLAGEN 7 AND ASSOCIATED METHODS
TWI592421B (zh) 2011-08-09 2017-07-21 双美生物科技股份有限公司 一種三重交聯之膠原蛋白、製造方法及其用途
AU2012312170C1 (en) 2011-09-21 2018-01-04 Shiseido Company, Ltd. Compositions and methods for treating conditions of compromised skin barrier function
JP5992529B2 (ja) * 2012-09-26 2016-09-14 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
US9591853B2 (en) 2013-01-07 2017-03-14 Ramot At Tel-Aviv University Ltd. Jellyfish-derived polymer
WO2014146175A1 (en) * 2013-03-21 2014-09-25 Commonwealth Scientific And Industrial Research Organisation Purification of triple helical proteins
CN105764920B (zh) 2013-09-09 2020-07-24 联邦科学工业研究组织 修饰的细菌胶原蛋白样蛋白
RU2016110800A (ru) 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
US10232008B1 (en) 2015-10-05 2019-03-19 Michael P. Moran Multi-purpose nutritional supplement composition
CN113797119A (zh) 2015-11-09 2021-12-17 株式会社资生堂 用于在皮肤上应用的组合物和方法
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
MX2018011162A (es) 2016-03-16 2018-11-22 Phoenix Tissue Repair Inc Metodos de purificacion de colageno 7.
CN106554410B (zh) 2016-06-02 2019-11-26 陕西东大生化科技有限责任公司 一种重组人源胶原蛋白及其编码基因和制备方法
CN106119322B (zh) 2016-07-22 2019-10-15 江苏江山聚源生物技术有限公司 一种提高重组人源胶原蛋白生产水平的发酵工艺
WO2018041684A1 (de) 2016-08-30 2018-03-08 Gelita Ag Verwendung von kollagenhydrolysat zur verbesserung der ausdauerleistungsfähigkeit und zur stimulation des fettabbaus
FR3058142B1 (fr) 2016-10-28 2023-11-24 Gelatines Weishardt Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament
CL2016003387A1 (es) 2016-12-29 2018-10-12 Univ De Santiago De Chile Usach Recubrimiento y/o película comestible para la conservación de productos cárneos
WO2019023555A1 (en) 2017-07-28 2019-01-31 Evelo Biosciences, Inc. POLYMER COMPOSITIONS
WO2019046943A1 (en) 2017-09-06 2019-03-14 University Of Ottawa PROTEINS OF THE COLLAGEN TYPE
GB201717134D0 (en) 2017-10-18 2017-12-06 Univ Swansea Monomeric collagen
US20200184381A1 (en) * 2017-11-22 2020-06-11 Geltor, Inc. Methods and systems for engineering collagen
DE102018104590A1 (de) 2018-02-28 2019-08-29 Gelita Ag Nutrazeutische oder pharmazeutische Zusammensetzung
SG11202110982WA (en) * 2019-04-01 2021-10-28 Geltor Inc Topical formulations of recombinant collagens
WO2020247438A1 (en) 2019-06-03 2020-12-10 Vital Proteins LLC Recover dietary supplement
GB2610313B (en) * 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003516730A (ja) 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2019068018A2 (en) 2017-09-28 2019-04-04 Geltor, Inc. RECOMBINANT COLLAGEN AND ELASTIN MOLECULES AND USES THEREOF

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
collagen alpha-1(XXI) chain [Phasianus colchicus]，Database NCBI Reference Sequence [online], NCBI, [検索日 2024.12.18], Retrieved from the Internet，2019年11月16日，<URL: https://www.ncbi.nlm.nih.gov/protein/XP_031466759.1/>，Accession No. XP_031466759

Also Published As

Publication number Publication date
CA3168802A1 (en) 2021-07-29
US20220017581A1 (en) 2022-01-20
MX2022009036A (es) 2022-11-14
GB202212264D0 (en) 2022-10-05
US11332505B2 (en) 2022-05-17
JP2023513435A (ja) 2023-03-31
BR112022014586A2 (pt) 2022-09-13
CN115298212A (zh) 2022-11-04
US20220332775A1 (en) 2022-10-20
GB2610313A (en) 2023-03-01
AU2021211721A1 (en) 2022-08-18
GB2610313B (en) 2024-07-03
EP4093761A1 (en) 2022-11-30
US11174300B2 (en) 2021-11-16
EP4093761A4 (en) 2024-04-17
TW202134267A (zh) 2021-09-16
WO2021150959A1 (en) 2021-07-29
US20210277075A1 (en) 2021-09-09

Similar Documents

Publication Publication Date Title
JP7794745B2 (ja) 動物質を含まない食事性コラーゲン
JP5689222B2 (ja) コラーゲンペプチド組成物及びこれを含有する飲食品
JP5890175B2 (ja) 血中移行性の高いコラーゲンペプチド組成物及びこれを含有する飲食品
JP5712393B2 (ja) コラーゲン類吸収促進剤及びその利用
JP2001031586A (ja) 動脈硬化症及び動脈硬化症に起因する疾患の予防又は治療組成物
WO2023192711A1 (en) Compositions and methods for delivering bioactive agents
JP6498437B2 (ja) 表皮基底膜保護剤
JP2007261999A (ja) ローヤルゼリー由来の降圧ペプチド
JP6061270B2 (ja) 米アルブミンを含有する血糖降下剤及び健康食品
JP2024074955A (ja) ペプチド、組成物及び気分障害を治療、予防、又は改善する方法
JP5394644B2 (ja) アスペルロシドまたはその類縁体を含む筋肉増強剤
JP6629469B1 (ja) コンドロイチン硫酸含有ブタ軟骨抽出物を有効成分とする血圧上昇抑制剤およびそれを含有する食品組成物
TW201043154A (en) Anti-mental fatigue agent
JP2020094015A (ja) ヒアルロン酸産生促進剤、関節機能改善剤、及び経口用組成物
KR101617770B1 (ko) 장 내 기생 선충에서 유래한 T.s 15-1 단백질을 유효성분으로 포함하는 피부 노화 억제 또는 상처 치료용 조성물
JP2025152733A (ja) 環状ペプチド、その生産方法、及びその利用
JP2023067042A (ja) 歩行機能における動的バランスの改善剤、転倒不安感の軽減剤および移動機能の低下を有する人に対する歩行機能改善剤
JP2025135641A (ja) 飲料
JP2013245168A (ja) アグリカン分解抑制剤
HK1169660A (en) Collagen peptide composition having good blood transfer properties, and food and drink containing same
KR20150110471A (ko) 조성물, 음식품, 내장지방 저감제 및 혈당치 저감제
HK1136586B (en) Collagen peptide composition and food or beverage containing the same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250321

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251022

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251218

R150 Certificate of patent or registration of utility model

Ref document number: 7794745

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150